Butia catarinensis Noblick & Lorenzi is a small palm (approximately 2 m high when full-grown) endemic to the southern coast of Brazil. Local farmers use the fruit and pulp for various purposes, and this extractive activity complements their income. The objective of this study was to understand the relationships between local people and B. catarinensis in its natural environment. Ethnobotanical and ethnoecological data were collected through participant observation, participatory research tools and semi-structured interviews. The density of B. catarinensis was measured in two areas, each containing twelve 10 m × 20 m plots. Interviewees recognized different varieties of the palm, its phenological stages, as well as potential pollinators and seed dispersers. Eighteen different uses for the palm were registered and three different collection practices were observed, depending on the purpose for which the fruit was used. The mean density in the two areas studied ranged from 38.6 to 7.9 adults per plot. The rate of production (per hectare) can be as high as 927 kg of fruit and 190 kg of pulp. The local community can contribute to the conservation of this coastal ecosystem through extractive activities of some scale, with potential environmental, economic and socio-cultural sustainability.

Os antipsicóticos podem estar associados a alterações cutâneas adversas. Relatamos o caso de uma paciente do sexo feminino, 47 anos, em acompanhamento ambulatorial com o diagnóstico de esquizofrenia. Estava em uso de ziprasidona há sete semanas. Prescrita inicialmente na dose de 80 mg ao dia, a medicação foi aumentada para 120 mg após seis semanas. Sete dias após o aumento da dose, a paciente apresentou quadro de prurido associado a lesões eritematosas em alvo, acometendo tronco, membros superiores e inferiores. Após a suspensão do antipsicótico, houve remissão do quadro dermatológico. Embora haja menção prévia a efeitos colaterais de natureza cutânea durante o uso desta medicação, não encontrou-se na literatura relatos de associação entre eritema multiforme e ziprasidona.

There are descriptions of skin reactions secondary to antipsychotic use. We reported a case of erythema multiform associated with ziprasidone use in a 47-year-old female patient diagnosed with schizophrenia. The patient was receiving the medication (80 mg/day) for seven weeks, and the dose was increased to 120 mg/day. Seven days after the dose change, the patient presented pruritus and erythematosus lesions in trunk, upper and lower members. The medication was discontinued and there was a complete improvement of the lesions. We were unable to find previous reports of association between erythema multiform and ziprasidone.